Arrowhead Pharmaceuticals, Inc. (ARWR)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Arrowhead Pharmaceuticals, Inc. (ARWR)
Go deeper and ask any question about ARWR
Company Performance
Current Price
as of Sep 13, 2024$21.49
P/E Ratio
N/A
Market Cap
$2.67B
Description
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Metrics
Overview
- HQPasadena, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerARWR
- Price$21.49+6.20%
Trading Information
- Market Cap$2.67B
- Float95.32%
- Average Daily Volume (1m)935,262
- Average Daily Volume (3m)1,026,036
- EPS-$4.65
Company
- Revenue$19.65M
- Rev Growth (1yr)-100.00%
- Net Income-$170.79M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$171.36M
- EV$3.25B
- EV/Revenue165.61
- P/EN/A
- P/S135.84
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset